7 May - Kristin Opdal Seljetun (VET)

Norwegian title of thesis
"Forekomst av antikoagulerende rotte- og musegifter hos hund og rødrev"

Prescribed subject of the trial lecture
“Non-clinical drug development”

Time and place for the trial lecture and the public defense

7 May 2021
- 1000hrs: Trial lecture
- 1045hrs: Break
- 1115hrs: Public defense

Zoom: https://nmbu.zoom.us/j/62281307455?pwd=bStBTUl4OFNiVk52TzFUWXNrQWhoZz09 

Evaluation committee
First Opponent: Dr. Bo Wiinberg, Novo Nordisk, Denmark
Second Opponent: Dr. Christiane Kruse Fæste, Norwegian Veterinary Institute, Norway
Committee Coordinator: Associate Professor Birgit Ranheim, NMBU, Norway

Main supervisor: Professor Lars Moe, NMBU, Norway
Co-supervisor: Dr. Vigdis Vindenes, Oslo University Hospital, Norway
Co-supervisor: Professor Tor Einar Horsberg, NMBU, Norway

Digital public defense
Due to restrictions related to the Covid-19 pandemic, a maximum of 5 people are allowed in the physical venue of the public defense. The general audience is therefore encouraged to attend the trial lecture and/or public defense via Zoom.

Guidelines for attending the defense via Zoom
- Do not use your camera.
- If anyone wishes to oppose Ex Auditorio, please ask your question in the chat before the 1st opponent ends his or her opposition.
- Testing of your own equipment is advised before attending.

The doctoral thesis is available for public review. For those who would like to have access to the thesis please send an e-mail to: forskerutdanning@nmbu.no.
Thesis number 2020:61, ISSN 1894-6402, ISBN 978-82-575-1728-1

Published 3. januar 2022 - 9:25 - Updated 3. januar 2022 - 9:25